Micro-vesicles derived from bone marrow stem cells protect the kidney both in vivo and in vitro by microRNA-dependent repairing

Nephrology

Volumn 20, Issue 9, 2015, Pages 591-600

  He, Juan ^a   Wang, Yan ^a   Lu, Xingyan ^a   Zhu, Bei ^a   Pei, Xiaohua ^a   Wu, Jianqing ^a   Zhao, Weihong ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

mesenchymal stem cell; microRNA; microvesicle; renal fibrosis

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; MICRORNA; TRANSFORMING GROWTH FACTOR BETA1; URIC ACID; UVOMORULIN; ACTA2 PROTEIN, HUMAN; ACTIN; BIOLOGICAL MARKER; CADHERIN; CDH1 PROTEIN, HUMAN; CREATININE; TGFB1 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL COMPARTMENTALIZATION; CELL CONTACT; CELL STRUCTURE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FUNCTION; KIDNEY TUBULE CELL; MEMBRANE MICROPARTICLE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RENAL PROTECTION; SUPERNATANT; UNILATERAL URETERAL OBSTRUCTION; UREA NITROGEN BLOOD LEVEL; URETER OBSTRUCTION; URIC ACID BLOOD LEVEL; ANIMAL; BLOOD; BONE MARROW TRANSPLANTATION; C57BL MOUSE; CELL LINE; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; KIDNEY; KIDNEY DISEASES; METABOLISM; PATHOLOGY; TIME FACTOR; TRANSPLANTATION;

ACTINS; ANIMALS; BIOMARKERS; BLOOD UREA NITROGEN; BONE MARROW TRANSPLANTATION; CADHERINS; CELL LINE; CELL-DERIVED MICROPARTICLES; CREATININE; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; KIDNEY; KIDNEY DISEASES; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE, INBRED C57BL; MICRORNAS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1; URETERAL OBSTRUCTION;

EID: 84939457521     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12490     Document Type: Article

References (25)

1. Bernardo ME, Locatelli F, Fibbe WE,. Mesenchymal stromal cells a novel treatment modality for tissue repair. Hematopoietic stem cells VII. Ann. N. Y. Acad. Sci. 2009; 1176: 101-117.
2. Tschöpe C, Miteva K, Schultheiss HP, Linthout SV,. Mesenchymal stromal cells: A promising cell source for the treatment of inflammatory cardiomyopathy. Curr. Pharm. Des. 2011; 17: 3295-3307.
3. Sassoli C, Pini A, Mazzanti B, etal. Mesenchymal stromal cells affect cardiomyocyte growth through juxtacrine Notch-1/Jagged-1 signaling and paracrine mechanisms: Clues for cardiac regeneration. J. Mol. Cell. Cardiol. 2011; 51: 399-408.
4. Morigi M, Imberti B, Zoja C, etal. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J. Am. Soc. Nephrol. 2004; 15: 1794-1804.
5. Morigi M, Introna M, Imberti B, etal. Human bone marrow-mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells 2008; 26: 2075-2082.
6. Herrera MB, Bussolati B, Bruno S, etal. Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int. 2007; 72: 430-441.
7. Herrera MB, Bussolati B, Bruno S, Fonsato V, Romanazzi GM, Camussi G,. Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int. J. Mol. Med. 2004; 14: 1035-1041.
8. Togel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C,. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am. J. Physiol. Renal Physiol. 2005; 289: F31-42.
9. Perico N, Casiraghi F, Introna M, etal. Autologous mesenchymal stromal cells and kidney transplantation: A pilot study of safety and clinical feasibility. Clin. J. Am. Soc. Nephrol. 2011; 6: 412-422.
10. Ninichuk V, Gross O, Segerer S, etal. Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. Kidney Int. 2006; 70: 121-129.
11. Choi S, Park M, Kim J, Hwang S, Park S, Lee Y,. The role of mesenchymal stem cells in the functional improvement of chronic renal failure. Stem Cells Dev. 2009; 18: 521-529.
12. Prunotto M, Moll S,. The emerging concept of a fibrotic microenvironment in CKD. Kidney Int. 2011; 79: 135.
13. Perico N, Casiraghi F, Gotti E, etal. Mesenchymal stromal cells and kidney transplantation: Pretransplant infusion protects from graft dysfunction while fostering immunoregulation. Transpl. Int. 2013; 26: 867-878.
14. Schorey JS, Bhatnagar S,. Exosome function: From tumor immunology to pathogen biology. Traffic 2008; 9: 871-881.
15. Deregibus MC, Cantaluppi V, Calogero R, etal. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 2007; 110: 2440-2448.
16. Bruno S, Grange C, Deregibus MC, etal. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J. Am. Soc. Nephrol. 2009; 20: 1053-1067.
17. He J, Wang Y, Sun S, etal. Bone marrow stem cells-derived microvesicles protect against renal injury in the mouse remnant kidney model. Nephrology 2012; 17: 493-500.
18. Gatti S, Bruno S, Deregibus MC, etal. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol. Dial. Transplant. 2011; 26: 1474-1483.
19. Lee J, Hwang L, Ha H,. Adenosine receptors are up-regulated in unilateral ureteral obstructed rat kidneys. Transplant. Proc. 2012; 44: 1166-1168.
20. Debeb BG, Zhang X, Krishnamurthy S, etal. Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells. Mol. Cancer 2010; 9: 180-191.
21. Collino F, Deregibus MC, Bruno S, etal. Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS ONE 2010; 5: e11803.
22. Chandrasekaran K, Karolina DS, Sepramaniam S, etal. Role of microRNAs in kidney homeostasis and disease. Kidney Int. 2012; 81: 617-627.
23. Lee RC, Feinbaum RL, Ambros V,. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75: 843-854.
24. Cantaluppi V, Gatti S, Medica D, etal. Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells. Kidney Int. 2012; 82: 412-427.
25. Valenti R, Huber V, Iero M, Filipazzi P, Parmiani G, Rivoltini L,. Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res. 2007; 67: 2912-2915.